Northern Trust Company of Connecticut’s Quest Diagnostics DGX Stock Holding History

Northern Trust Company of Connecticut’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$6.18M	Buy	115,428 +2,483	+2%	+$147K	0.04%	606
2013 Q3	$6.98M	Sell	112,945 -6,587	-6%	-$394K	0.05%	571
2013 Q2	$7.25M	Buy	+119,532	New	+$7.12M	0.05%	534

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's DGX Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Quest Diagnostics (DGX) stake by 2.2% in Q4 2013, buying an estimated $147K and bringing the position to 115,428 shares worth $6.18M. The position accounts for 0.04% of the portfolio, ranked #606.

Northern Trust Company of Connecticut first reported a position in DGX in Q2 2013 and has held it in 3 quarters since. The position peaked at $7.25M in Q2 2013. 455 funds tracked by Wall St. Rank hold DGX as of Q4 2013.

Northern Trust Company of Connecticut held 115,428 shares of Quest Diagnostics worth $6.18M as of Q4 2013.
Northern Trust Company of Connecticut bought 2,483 Quest Diagnostics shares in Q4 2013, an estimated $147K.
Quest Diagnostics made up 0.04% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #606 holding.
Northern Trust Company of Connecticut first reported a position in Quest Diagnostics in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's Quest Diagnostics position peaked at $7.25M in Q2 2013.
455 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.